| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 11039742 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 477 journal articles in the PubMed database | Email to a friend | | |
| Javitt J, Goldberg I
Comparison of the clinical success rates and quality of life effects of brimonidine tartrate 0.2% and betaxolol 0.25% suspension in patients with open-angle glaucoma and ocular hypertension. Brimonidine Outcomes Study Group II. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Glaucoma 2000 Oct; 9(5):398-408.
Abstract | Full Citation | Find Related Articles | | Javitt JC, Schiffman RM
Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular t hypertension: a randomized clinical trial. Brimonidine Outcomes Study Group I. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
J Glaucoma 2000 Jun; 9(3):224-34.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Serle JB
A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Surv Ophthalmol 1996 Nov.:S39-47.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cantor LB, Hoop J, Katz LJ, et al.
Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25 % suspension in patients with elevated intraocular pressure. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2001 Jul; 23(7):1032-9.
Abstract | Full Citation | Find Related Articles | | LeBlanc RP
Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ophthalmology 1998 Oct; 105(10):1960-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | DuBiner HB, Mroz M, Shapiro AM, et al.
A comparison of the efficacy and tolerability of brimonidine and latanoprost in adults with open-angle glaucoma or ocular hypertension: a three-month, multicenter, randomized, double-masked, parallel-group trial. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 2001 Dec; 23(12):1969-83.
Abstract | Full Citation | Find Related Articles | | Schuman JS
Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ophthalmology 2000 Jun; 107(6):1171-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Katz LJ
Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily: 1-year results in glaucoma patients. Brimonidine Study Group. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Ophthalmol 1999 Jan; 127(1):20-6.
Abstract | Full Citation | Find Related Articles | | Simmons ST, Earl ML
Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on beta-blockers: tolerance and peak intraocular pressure lowering. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Ophthalmology 2002 Feb; 109(2):307-14; discussion 314-5.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
